Welcome

United States Hypolipidemic Prescription Markets

 

  • Research Code : 5388-01-00-00-00
  • SKU : HC00224-NA-MR_03180
  • Share this :
  • Release Date : 12-Apr-2000
  • Region : North America
  • Request Study Sample

Availability: In stock

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

Pay By Invoice

Be the first to review this product



Table of Contents

United States Hypolipidemic Prescription Markets, Executive Summary

Introduction to the Hypolipidemic Prescription Market (U.S.) 1996-2006

Objectives and Purpose
Report Scope and Segmentation
Market Definition
Report Structure
Patient Population Statistics

Summary of Major Findings

Summary of Major Findings
Drivers Affecting the U.S. Hypolipidemic Prescription Market
Restraints Affecting the U.S. Hypolipidemic Prescription Market
Total Revenue Forecasts

Competitive Analysis

Competitive Structure
Competitive Factors
Mergers and Acquisitions

United States Hypolipidemic Prescription Markets, Market Engineering Research Methodology

Research Scope

Objectives and Purpose

Market Engineering Forecasting Methodology

Overview
Strategic Significance of the Market Engineering Forecast
Judging Credibility and Accuracy of Market Engineering Forecasts
Forecast Assumptions

Glossary of Terms

List of Definitions
List of Acronyms

United States Hypolipidemic Prescription Markets, Industry Challenges

Identification of Challenges Facing the U.S. Hypolipidemic Prescription Industry

Identification of Challenges Facing the U.S. Hypolipidemic Prescription Industry
Inventing New Strategies Prevents Market Share Confiscation from New Market Entrants
Promoting the Benefits of One Drug over Another Raises Market Share
Broadening Indications Stresses the Competitive Advantage of Products to Expand Opportunities
Influencing the Composition of Adult Treatment Panel Guidelines Directly Influences Physician Prescription Patterns
Detailing the Benefits of Products to Untreated Patients Offers Additional Market Opportunities
Reducing Follow-up Tests Increases Prescription Writing and the Likelihood of Rx to OTC Switches
Pooling Resources in Co-Promotion Alliances Surpasses Marketing Endeavors of Unaccompanied Market Players
Inventing New Strategies Attracts Managed Care Organizations and Generates Greater Revenues
Directing Research Towards the Benefits of Treating Lipids Other Than LDL Cholesterol Imperils the Statin Drug Market
Maintaining Diligence on Pricing Trends as Patent Expiration Approaches Creates Higher Earnings

Market Engineering Research for the U.S. Hypolipidemic Prescription Market 1996-2006

Market Overview and Definitions

Overview
Market Definition
Scope/Segmentation

Product Analysis

Products on the Market

Research Measurement System

Research Measurement System

Market Drivers

Market Drivers
Direct-to-Consumer Advertising Captures New Patient Targets and Elevates Growth in Penetration Rates
Expanding Indications of Hypolipidemic Drugs Identify New Benefits of Drugs
Physician Detailing Educates Benefits of Statin Drugs
New Patient Populations Arise from Direct-to-Consumer Advertising
Attention Towards HDL as a Preventative Risk Factor Ignites New Promotion Strategies
Novel Approaches to Risk Factors of Cardiovascular Morbidity and Mortality Opens New Opportunities for Statin Drugs
NCQA Accreditation Ensures That Drugs Will Increase Revenues of Non-Statin Entities
Manufacturers Support Mass Cholesterol Screening to Identify New Patients and Promote Cholesterol Awareness
Discoveries in the Benefits of Treating Other Lipids to Reduce One’s Risk for Heart Disease May Open Opportunities for New Therapies

Market Restraints

Market Restraints
Introduction of ZD-4522 in 2001 Confiscates Market Shares of Statin Drugs
Patient Noncompliance Disrupts Patient Treatment Strategies
Patent Expiration Poses a Threat to Branded Drugs
Frequent Follow-ups May Promote Patient Noncompliance
Opposition to DTC Advertising Stunts Marketing Efforts
Medicare Creates Neglected Patient Targets by Limiting Coverage for Routine Cholesterol Screening
Potential Change of Prognostic Markers of Cardiovascular Disease Shifts Prophylactic Treatment Strategies
OTC Drugs Dislocate Prescribing Trends and Market Distribution
Nutraceuticals May Compete with Prescription Drugs

Market Engineering Total Revenue Forecasts (2000-2006)

Demand Analysis
Market Engineering and Revenue Forecasts (1996-2006)
Major Trends

Competitive Analysis

Competitive Structure
Competitive Factors
Market Share Analysis
Market Share Winners and Why
Market Share Losers and Why

Market Engineering Research for the Emerging U.S. Hypolipidemic Prescription Market

Market Overview

Market Overview
Scope
Products in clinical trials
Emerging Small Molecule Therapies

Technology Trends

HDL Elevating Therapies
LDL Receptor Based Therapies
Emphasis on Combination Therapy
Acceleration Towards Atherogenic Findings
Hormone Related Therapy to Improve Lipid Profile

NIH appropriations

NIH appropriations

Compounds Interfering with Cholesterol Absorption and Excretion

Lipid Formulations
Saponins

Compounds Near FDA Approval

ZD-4522
Cholestagel

Opportunities for Partnership

Opportunities for Partnership

Discontinued Development

Discontinued Development

United States Hypolipidemic Prescription Markets, Market Engineering Strategy

Market Engineering Strategic Recommendations

Market Engineering Strategic Recommendations
Corporate Management
Marketing Department
Research and Development
Sales

Market Engineering Awards for the Hypolipidemic Prescription Market (U.S.), 1999

Frost & Sullivan's 1999 Market Engineering Awards

Frost & Sullivan's 1999 Market Engineering Awards

Market Engineering Awards

Market Engineering Awards
Award Category: Market Engineering Leadership
Award Category: Business Development Strategy
Award Category: Entrepreneurial Company


Sample Study






Related Research
WHY CHOOSE
FROST & SULLIVAN
RESEARCH ?

1. Primary Research

Our analysis is based on comprehensive primary research conducted with core market participants.

2. Global Coverage

Unparalleled coverage of geographies, our analyst & consultant teams are based in 42+ offices spanning the globe.

3. Breadth of Vertical Industries

We cover the broadest spectrum of markets to provide our clients with the most relevant analysis and transformational insights.

4. Visionary Innovation Research

With on-going transformational shifts, our visionary innovation research prepares you with information on key megatrends shaping the future of your industry.

5. Mega Trends

Mega Trends are global forces that transform business, societies and economies.

6. Convergence Research Coverage

Taking an approach of analysing a macro-to-micro impact, our convergence research helps you prepare against an impending 'Kodak moment'.